Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Incyte Corporation(INCY) | 30,743,663 | 30,743,991 | +328 | $2.61B | $3.04B | 17.78% | +$429.21M |
| BeOne Medicines AGADS(ONC) | 8,799,053 | 8,799,053 | 0 | $3.00B | $2.67B | 15.65% | -$324.60M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 2,141,701 | 2,141,701 | 0 | $982.31M | $1.25B | 7.30% | +$264.89M |
| Insmed Incorporated(INSM) | 6,703,484 | 6,592,746 | -110,738 | $965.37M | $1.15B | 6.72% | +$182.03M |
| ACADIA Pharmaceuticals Inc. | 42,896,690 | 42,896,690 | 0 | $915.42M | $1.15B | 6.71% | +$230.36M |
| Celcuity Inc.(CELC) | 7,915,792 | 7,915,792 | 0 | $391.04M | $789.52M | 4.62% | +$398.48M |
| Revolution Medicines, Inc.(RVMD) | 9,455,357 | 9,455,357 | 0 | $441.57M | $753.12M | 4.41% | +$311.55M |
| Kymera Therapeutics, Inc.(KYMR) | 6,651,429 | 8,657,242 | +2,005,813 | $376.47M | $673.62M | 3.94% | +$297.15M |
| Summit Therapeutics Inc.(SMMT) | 33,722,974 | 36,391,063 | +2,668,089 | $696.72M | $636.48M | 3.73% | -$60.24M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 5,604,483 | 5,604,483 | 0 | $566.00M | $599.90M | 3.51% | +$33.91M |
| Kodiak Sciences Inc.(KOD) | 17,310,490 | 19,919,186 | +2,608,696 | $283.37M | $556.94M | 3.26% | +$273.57M |
| Praxis Precision Medicines, Inc.(PRAX) | 689,488 | 1,126,488 | +437,000 | $36.54M | $332.02M | 1.94% | +$295.48M |
| Alkermes plcSHS(ALKS) | 8,091,351 | 10,012,267 | +1,920,916 | $242.74M | $280.14M | 1.64% | +$37.40M |
| GRAIL, Inc.(GRAL) | 1,630,125 | 2,085,333 | +455,208 | $96.39M | $178.48M | 1.05% | +$82.09M |
| Edgewise Therapeutics, Inc.(EWTX) | 7,305,940 | 6,575,940 | -730,000 | $118.50M | $163.18M | 0.96% | +$44.68M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 1,670,762 | 2,175,645 | +504,883 | $57.62M | $144.44M | 0.85% | +$86.82M |
| Ionis Pharmaceuticals, Inc.(IONS) | 566,798 | 1,791,841 | +1,225,043 | $37.08M | $141.75M | 0.83% | +$104.67M |
| Immunovant, Inc.(IMVT) | 5,457,881 | 5,457,881 | 0 | $87.98M | $138.74M | 0.81% | +$50.76M |
| Immatics N.V.SHS(IMTX) | 12,094,094 | 12,094,094 | 0 | $103.04M | $126.99M | 0.74% | +$23.95M |
| IDEAYA Biosciences, Inc.(IDYA) | 3,275,444 | 3,618,826 | +343,382 | $89.12M | $125.10M | 0.73% | +$35.98M |
| Roivant Sciences Ltd.SHS(ROIV) | 3,767,773 | 5,555,017 | +1,787,244 | $57.01M | $120.54M | 0.71% | +$63.54M |
| ABIVAX Société AnonymeADS(ABVX) | 875,796 | 875,796 | 0 | $74.36M | $118.11M | 0.69% | +$43.75M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 2,824,669 | 2,826,246 | +1,577 | $109.68M | $116.58M | 0.68% | +$6.90M |
| Replimune Group, Inc.(REPL) | 11,045,336 | 11,045,336 | 0 | $46.28M | $107.36M | 0.63% | +$61.08M |
| Stoke Therapeutics, Inc.(STOK) | 4,633,838 | 3,336,697 | -1,297,141 | $108.90M | $105.91M | 0.62% | -$2.99M |
| Structure Therapeutics Inc.ADS | 1,556,109 | 1,432,529 | -123,580 | $43.57M | $99.63M | 0.58% | +$56.06M |
| AbCellera Biologics Inc.(ABCL) | 27,525,640 | 27,525,640 | 0 | $138.45M | $94.14M | 0.55% | -$44.32M |
| Nurix Therapeutics, Inc.(NRIX) | 3,882,125 | 4,658,556 | +776,431 | $35.87M | $88.37M | 0.52% | +$52.50M |
| Immunocore Holdings plcADS(IMCR) | 2,322,656 | 2,322,656 | 0 | $84.38M | $80.62M | 0.47% | -$3.76M |
| Bicycle Therapeutics plcADS | 10,885,357 | 10,885,357 | 0 | $84.25M | $77.07M | 0.45% | -$7.18M |
| Crinetics Pharmaceuticals, Inc. | 280,000 | 1,648,869 | +1,368,869 | $11.66M | $76.75M | 0.45% | +$65.09M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 4,916,095 | 4,345,736 | -570,359 | $36.43M | $68.14M | 0.40% | +$31.71M |
| Celcuity Inc.NOTE 2 75 8 1 2031(CELC) | 0 | 0 | 0 | $40.91M | $66.58M | 0.39% | +$25.67M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 2,772,692 | 2,772,692 | 0 | $83.40M | $63.77M | 0.37% | -$19.63M |
| Denali Therapeutics Inc.(DNLI) | 3,731,695 | 3,731,695 | 0 | $54.18M | $61.61M | 0.36% | +$7.43M |
| Viridian Therapeutics, Inc.(VRDN) | 1,744,406 | 1,971,678 | +227,272 | $37.64M | $61.36M | 0.36% | +$23.71M |
| Entrada Therapeutics, Inc.(TRDA) | 4,865,819 | 5,072,730 | +206,911 | $28.22M | $52.15M | 0.31% | +$23.93M |
| Rapport Therapeutics, Inc.(RAPP) | 1,547,090 | 1,547,090 | 0 | $45.95M | $46.94M | 0.27% | +$990.1K |
| Terns Pharmaceuticals, Inc. | 0 | 950,000 | +950,000 | $0 | $38.38M | 0.22% | +$38.38M |
| BioNTech SEADS(BNTX) | 368,923 | 368,923 | 0 | $36.38M | $35.12M | 0.21% | -$1.26M |
| Spyre Therapeutics, Inc.(SYRE) | 1,000,000 | 1,000,000 | 0 | $16.76M | $32.76M | 0.19% | +$16.00M |
| Dianthus Therapeutics, Inc.(DNTH) | 789,759 | 789,759 | 0 | $31.08M | $32.55M | 0.19% | +$1.47M |
| Prelude Therapeutics Incorporated(PRLD) | 10,123,824 | 10,123,824 | 0 | $14.58M | $29.36M | 0.17% | +$14.78M |
| DBV Technologies S.A.ADS(DBVT) | 1,461,425 | 1,461,425 | 0 | $14.61M | $28.02M | 0.16% | +$13.40M |
| Disc Medicine, Inc.(IRON) | 337,050 | 337,050 | 0 | $22.27M | $26.77M | 0.16% | +$4.49M |
| Jade Biosciences, Inc. | 0 | 1,641,137 | +1,641,137 | $0 | $25.32M | 0.15% | +$25.32M |
| Taysha Gene Therapies, Inc.(TSHA) | 4,004,756 | 4,004,756 | 0 | $13.10M | $22.03M | 0.13% | +$8.93M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 0 | 2,822,727 | +2,822,727 | $0 | $22.02M | 0.13% | +$22.02M |
| Ventyx Biosciences, Inc. | 1,023,130 | 2,349,280 | +1,326,150 | $3.18M | $21.21M | 0.12% | +$18.03M |
| argenx SEADR(ARGX) | 37,760 | 25,174 | -12,586 | $27.85M | $21.17M | 0.12% | -$6.68M |
| Design Therapeutics, Inc.(DSGN) | 1,712,882 | 2,233,099 | +520,217 | $12.90M | $20.95M | 0.12% | +$8.05M |
| Cerus Corporation(CERS) | 10,008,345 | 10,008,345 | 0 | $15.91M | $20.62M | 0.12% | +$4.70M |
| Neurogene Inc.(NGNE) | 991,691 | 991,691 | 0 | $17.19M | $20.43M | 0.12% | +$3.24M |
| Tectonic Therapeutic, Inc.(TECX) | 100,000 | 903,400 | +803,400 | $1.57M | $18.84M | 0.11% | +$17.28M |
| CytomX Therapeutics, Inc.(CTMX) | 4,250,826 | 4,250,826 | 0 | $13.56M | $18.11M | 0.11% | +$4.55M |
| Celldex Therapeutics, Inc.(CLDX) | 665,370 | 665,370 | 0 | $17.21M | $18.07M | 0.11% | +$858.3K |
| Xencor, Inc.(XNCR) | 1,102,106 | 1,102,106 | 0 | $12.93M | $16.87M | 0.10% | +$3.95M |
| Centessa Pharmaceuticals plcADS | 0 | 670,751 | +670,751 | $0 | $16.78M | 0.10% | +$16.78M |
| Xenon Pharmaceuticals Inc.(XENE) | 370,208 | 370,208 | 0 | $14.86M | $16.59M | 0.10% | +$1.73M |
| Sionna Therapeutics, Inc.(SION) | 400,000 | 400,000 | 0 | $11.76M | $16.46M | 0.10% | +$4.69M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 77,670 | 1,420,838 | +1,343,168 | $912.6K | $16.24M | 0.10% | +$15.33M |
| Sera Prognostics, Inc.CL A(SERA) | 5,498,170 | 5,498,170 | 0 | $16.82M | $16.22M | 0.09% | -$604.8K |
| Dyne Therapeutics, Inc.(DYN) | 0 | 813,449 | +813,449 | $0 | $15.91M | 0.09% | +$15.91M |
| Alumis Inc. | 1,562,500 | 1,562,500 | 0 | $6.23M | $15.25M | 0.09% | +$9.02M |
| Nuvalent, Inc. | 143,937 | 143,937 | 0 | $12.45M | $14.48M | 0.08% | +$2.03M |
| Pharvaris N.V. COM | 375,000 | 375,000 | 0 | $9.36M | $10.41M | 0.06% | +$1.05M |
| Relay Therapeutics, Inc.(RLAY) | 1,160,117 | 1,160,117 | 0 | $6.06M | $9.81M | 0.06% | +$3.76M |
| Absci Corporation | 0 | 2,134,803 | +2,134,803 | $0 | $7.45M | 0.04% | +$7.45M |
| Arcus Biosciences, Inc.(RCUS) | 0 | 270,000 | +270,000 | $0 | $6.43M | 0.04% | +$6.43M |
| MapLight Therapeutics, Inc.(MPLT) | 0 | 364,705 | +364,705 | $0 | $6.41M | 0.04% | +$6.41M |
| vTv Therapeutics Inc.CL A(VTVT) | 148,314 | 148,314 | 0 | $3.46M | $5.93M | 0.03% | +$2.47M |
| Wave Life Sciences, Inc.SHS(WVE) | 344,063 | 344,063 | 0 | $2.52M | $5.85M | 0.03% | +$3.33M |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 952,996 | 952,996 | 0 | $6.54M | $5.64M | 0.03% | -$895.8K |
| Protara Therapeutics, Inc.(TARA) | 536,832 | 971,614 | +434,782 | $2.34M | $5.18M | 0.03% | +$2.84M |
| LB Pharmaceuticals Inc(LBRX) | 200,000 | 200,000 | 0 | $3.16M | $4.45M | 0.03% | +$1.29M |
| Enliven Therapeutics, Inc. | 114,833 | 271,406 | +156,573 | $2.35M | $4.18M | 0.02% | +$1.83M |
| 4D Molecular Therapeutics, Inc. | 0 | 475,737 | +475,737 | $0 | $3.57M | 0.02% | +$3.57M |
| Vir Biotechnology, Inc.(VIR) | 542,539 | 542,539 | 0 | $3.10M | $3.27M | 0.02% | +$173.6K |
| TScan Therapeutics, Inc.(TCRX) | 2,784,792 | 2,784,792 | 0 | $5.07M | $2.78M | 0.02% | -$2.28M |
| Sana Biotechnology, Inc.(SANA) | 2,030,949 | 310,483 | -1,720,466 | $7.21M | $1.26M | 0.01% | -$5.95M |
| Skye Bioscience, Inc.(SKYE) | 1,450,638 | 1,450,638 | 0 | $5.70M | $1.09M | 0.01% | -$4.61M |
| KALA BIO, Inc.(KALA) | 985,093 | 1,804,055 | +818,962 | $1.51M | $1.00M | 0.01% | -$504.3K |
| Aligos Therapeutics, Inc.(ALGS) | 83,055 | 83,055 | 0 | $813.9K | $774.1K | 0.00% | -$39.9K |
| Tyra Biosciences, Inc.(TYRA) | 10,607 | 10,607 | 0 | $148.4K | $278.9K | 0.00% | +$130.5K |
| Acrivon Therapeutics, Inc. | 22,809 | 22,809 | 0 | $41.3K | $55.0K | 0.00% | +$13.7K |
| Surrozen, Inc.W EXP 8 11 2026(SRZN) | 833,333 | 833,333 | 0 | $14.8K | $16.7K | 0.00% | +$1.8K |
| Agios Pharmaceuticals, Inc.(AGIO) | 189,866 | 0 | -189,866 | $7.62M | $0 | — | -$7.62M |
| Akero Therapeutics, Inc. | 324,630 | 0 | -324,630 | $15.41M | $0 | — | -$15.41M |
| Arcellx, Inc. COMMON STOCK | 166,825 | 0 | -166,825 | $13.70M | $0 | — | -$13.70M |
| Avidity Biosciences, Inc. | 625,000 | 0 | -625,000 | $27.23M | $0 | — | -$27.23M |
| Cidara Therapeutics, Inc. | 227,272 | 0 | -227,272 | $21.76M | $0 | — | -$21.76M |
| Generation Bio Co. | 194,493 | 0 | -194,493 | $1.19M | $0 | — | -$1.19M |
| Heron Therapeutics, Inc.(HRTX) | 4,251,951 | 0 | -4,251,951 | $5.36M | $0 | — | -$5.36M |
| Intellia Therapeutics, Inc.(NTLA) | 2,746,674 | 0 | -2,746,674 | $47.44M | $0 | — | -$47.44M |
| MBX Biosciences, Inc.(MBX) | 277,777 | 0 | -277,777 | $4.86M | $0 | — | -$4.86M |
| Merus N.V. | 574,377 | 0 | -574,377 | $54.08M | $0 | — | -$54.08M |
| Ceryvyn Therapeutics LimitedADS(CKDXF) | 2,087,320 | 0 | -2,087,320 | $0 | $0 | — | $0 |
| Vaxcyte, Inc.(PCVX) | 640,885 | 0 | -640,885 | $23.08M | $0 | — | -$23.08M |
| Viking Therapeutics, Inc.(VKTX) | 366,083 | 0 | -366,083 | $9.62M | $0 | — | -$9.62M |
| Yarrow Bioscience Inc(YARW) | 851,353 | 0 | -851,353 | $285.2K | $0 | — | -$285.2K |